Mylan Resolves Shire Suit Over Generic Fosrenol
Shire US Inc. on Tuesday ended its patent infringement suit in New York against Mylan Inc. and Matrix Laboratories Ltd. over a generic version of the drug Fosrenol, which reduces phosphate...To view the full article, register now.
Already a subscriber? Click here to view full article